Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, raised another $200 million for its research.
The company has sequenced what Lamm described as the highest-quality ancient genome to date for any animal. The dodo is proving most challenging, Lamm said. Colossal has established a flock of ...